Digital Strategies to Advance Help-Seeking - Aim 3
Launched by COLUMBIA UNIVERSITY · Jan 13, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping young people, ages 13 to 26, who are at high risk of developing psychosis, which is a serious mental health condition that can affect how a person thinks, feels, and behaves. The goal is to create a Digital Laboratory that will make it easier for these young individuals to seek help and start treatment earlier. Researchers will study a large group of about 25,000 youth who may be at risk and will develop personalized strategies to encourage them to reach out for care. They will also work to improve online screening tools so that it's easier to identify those who need help and connect them with local mental health services.
To participate in this trial, you need to be between 13 and 26 years old, live within 50 miles of a participating site in the U.S., and be able to complete a specific online screening in English. While the study is not yet recruiting participants, those who take part can expect to contribute to important research that aims to make mental health support more accessible for young people facing challenges. This is an exciting opportunity to be part of a project that could help many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 12-29 years
- • Living within a 50-mile radius of a US based AMP-SCZ site
- • Able to complete the English language PQ-B on MHA's screening platform
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael Birnbaum, MD
Principal Investigator
Columbia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported